BUSTI, Fabiana
 Distribuzione geografica
Continente #
NA - Nord America 2.021
EU - Europa 1.690
AS - Asia 1.071
SA - Sud America 81
AF - Africa 19
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 4.893
Nazione #
US - Stati Uniti d'America 2.007
GB - Regno Unito 523
CN - Cina 518
SG - Singapore 369
SE - Svezia 216
RU - Federazione Russa 171
IE - Irlanda 157
FR - Francia 151
IT - Italia 149
DE - Germania 122
FI - Finlandia 105
BR - Brasile 68
KR - Corea 36
HK - Hong Kong 32
UA - Ucraina 30
BE - Belgio 26
JP - Giappone 25
VN - Vietnam 21
CA - Canada 11
ID - Indonesia 11
IR - Iran 10
TG - Togo 10
TR - Turchia 10
PK - Pakistan 9
IQ - Iraq 7
AU - Australia 6
CZ - Repubblica Ceca 6
IN - India 6
GR - Grecia 5
EG - Egitto 4
ES - Italia 4
VE - Venezuela 4
AR - Argentina 3
AT - Austria 3
BD - Bangladesh 3
CH - Svizzera 3
EU - Europa 3
HR - Croazia 3
NL - Olanda 3
BO - Bolivia 2
CL - Cile 2
KG - Kirghizistan 2
MD - Moldavia 2
MX - Messico 2
OM - Oman 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
IL - Israele 1
IM - Isola di Man 1
KE - Kenya 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 4.893
Città #
Southend 463
Chandler 416
Singapore 246
Jacksonville 226
Ann Arbor 164
Dublin 155
Ashburn 148
Woodbridge 130
Beijing 95
New York 90
Wilmington 66
Houston 64
Lawrence 59
Princeton 59
Verona 50
Helsinki 46
Jinan 43
Boardman 40
Nanjing 40
Shenyang 27
Hong Kong 25
Brussels 24
Tokyo 24
Lancaster 20
Redmond 20
Haikou 18
Sindelfingen 18
Hebei 17
Zhengzhou 17
Falls Church 16
Munich 16
Ningbo 16
Seoul 16
Nanchang 15
Tianjin 14
Seattle 13
Changsha 12
Guangzhou 11
Los Angeles 11
Taizhou 11
Lomé 10
Milan 10
Redwood City 10
Santa Clara 10
Taiyuan 10
Jiaxing 9
Fuzhou 8
London 8
Norwalk 8
Toronto 8
Council Bluffs 7
Jakarta 7
Lanzhou 7
Tehran 7
Villarbasse 7
Fairfield 6
Hangzhou 6
Rome 6
San Francisco 6
São Paulo 6
Alexandria 5
Dong Ket 5
Nettuno 5
Brno 4
Cagliari 4
Chions 4
Dallas 4
Düsseldorf 4
Falkenstein 4
Nuremberg 4
Seongbuk-gu 4
Washington 4
Athens 3
Bangalore 3
Cerea 3
Kent 3
Kirkuk 3
Madrid 3
Mehlingen 3
Moscow 3
San Mateo 3
Shanghai 3
Zurich 3
Antibes 2
Aparecida de Goiânia 2
Bandung 2
Berlin 2
Bishkek 2
Cairo 2
Canberra 2
Carapicuíba 2
Central 2
Chengdu 2
Chicago 2
Chisinau 2
Coro 2
Corridonia 2
Curitiba 2
Dearborn 2
Dhaka 2
Totale 3.235
Nome #
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 133
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 131
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 123
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload 122
Identification of new BMP6 pro-peptide mutations in patients with iron overload 116
A challenging case of abdominal pain associated to Helicobacter pylori infection 114
Genomics of coronary artery disease and myocardial infarction. From Genome Wide Association Studies to the Next-Generation-Sequencing era 112
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.c282y homozygous patients. 109
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 108
Paraoxonase-1 status in patients with hereditary hemochromatosis 107
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian Patients with Iron Overload and Non-Diagnostic First Level Genetic Test: A Pilot Study 107
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 106
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 104
DISHphagia: An Unusual Cause of Dysphagia. J Clin Endocrinol Metab. 104
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 103
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 101
Hepcidin suppression relative to iron status in patients with chronic Hepatitits C 100
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease but not with mortality in the setting of secondary prevention 100
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 99
Altered paraoxonase expression in patients with genetic haemochromatosis. 99
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 99
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 95
Serum Hepcidin Levels Correlate with Phenotypes of the Metabolic Syndrome At Population Level 92
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 91
HEPCIDIN SUPPRESSION IN BETA-THALASSEMIA CARRIERS WITH IRON OVERLOAD. Preliminary reports from an ongoing study. 91
Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis 87
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 85
COBALAMIN DEFICIENCY IN THE ELDERLY 83
Reduced serum hepcidin levels in patients with chronic hepatitis C 81
GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors 78
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 76
Anemia and adverse outcomes in the elderly: a detrimental inflammatory loop? 76
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 70
Paraoxonase-1 status in patients with hereditary hemochromatosis. 69
Iron replacement therapy: entering the new era without misconceptions, but more research is needed 68
An unusual case of inferior vena cava thrombosis: widening the differential diagnosis 68
Modern iron replacement therapy: clinical and pathophysiological insights 66
Therapeutic oligonucleotides in cardiovascular and metabolic diseases: insights for the internist 64
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 63
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease 62
Hyperferritinemia and diagnosis of type 1 Gaucher disease 62
Anemia and iron deficiency in heart failure: extending evidences from chronic to acute setting 62
Iron deficiency in the elderly population, revisited in the hepcidin era. 59
Practical implications of the 2019 Nobel Prize in Physiology or Medicine: from molecular adaptation to hypoxia to novel anti-anemic drugs in the clinic 59
Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease 59
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 59
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? 56
Is Ferroptosis a Key Component of the Process Leading to Multiorgan Damage in COVID-19? 56
Iron replacement in inflammatory bowel disease: an evolving scenario 55
Proprotein convertase 7 rs236918 is associated with liver fibrosis in Italian patients with HFE-related Hemochromatosis 54
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian patients with Iron Overload and Non-diagnostic First Level Genetic Test.A Pilot Study 51
Iron metabolism in infections: Focus on COVID-19 51
Impact of natural Neuromedin-B receptor variants on iron metabolism 49
Treatment options for anemia in the elderly 48
ERFE regulation in sickle cell disease: complex but promising 46
Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments 42
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 42
Hemochromatosis classification: update and recommendations by the BIOIRON Society 39
The Role of Iron Staining in Myelodysplastic Syndromes: A Treasure Trove of Information 38
The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study 23
Sparing unnecessary transfusions through patient blood management: time for application also in internal and emergency medicine 21
New Insights into the Role of Ferroptosis in Cardiovascular Diseases 21
Serum Erythroferrone in a Large General Population: Towards a Better Understanding of Connections Between Erythropoiesis and Iron Homeostasis 21
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 20
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study 19
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study 18
Use of non-invasive respiratory supports in high-intensity internal medicine setting during the first two waves of the COVID-19 pandemic emergency in Italy: a multicenter, real-life experience 18
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 17
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches 16
Recent Advancements in Hematology: Knowledge, Methods and Dissemination-1 16
Recent Advancement of Hematology: Know, How to Do, Let Know 13
Manipulating hepcidin in polycythemia vera 11
Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia 10
Clonal hematopoiesis in cardiovascular aging: Insights from the verona heart study 5
Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach 2
Totale 5.000
Categoria #
all - tutte 19.585
article - articoli 14.357
book - libri 0
conference - conferenze 4.969
curatela - curatele 0
other - altro 259
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020104 0 0 0 0 0 0 0 0 0 49 18 37
2020/2021434 19 76 22 49 78 52 18 17 10 18 50 25
2021/2022530 15 159 3 63 20 23 7 28 20 17 50 125
2022/20231.143 67 132 94 198 100 254 22 87 139 4 24 22
2023/2024665 21 36 49 58 54 149 21 48 7 32 96 94
2024/20251.001 82 111 65 255 71 50 94 71 195 7 0 0
Totale 5.000